Connect with us
Johnson & Johnson announced a new investment as part of its $55 billion US expansion, including a Montgomery County biomanufacturing site creating 500 permanent jobs and...
Onyx Biotech has raised pre-seed funding from Life Science Valley Growth Fund, Freiraum Ventures, and business angels to advance AI-driven drug development. Founded in 2024, the...
BB Biotech actively restructured its portfolio in early 2026, adding eleven stocks and expanding investment guidelines. Its share price outperformed net asset value, narrowing the valuation...
Spanish hospitals are applying AI, deep learning, and digital tools to improve diagnosis, predict disease demand, and enhance prevention. Projects presented at the Gate2Health meeting show...
Saxony’s biotech sector seeks more venture capital, faster approvals, and greater AI use to sustain growth. The state continues investing, expanding hubs like Bioz and Biocity,...
Beeline Medicines launches globally with $300M funding and Bristol Myers Squibb assets to develop precision therapies for autoimmune and inflammatory diseases. Led by Saqib Islam, it...
Novo Nordisk has partnered with OpenAI to use advanced artificial intelligence in drug discovery, data analysis, and operations. The collaboration aims to speed research, improve efficiency...
A 47-year-old woman with three severe autoimmune diseases received CAR-T cell therapy at a German hospital, achieving one-year remission without further treatment. After years of failed...
Gilead is acquiring German biotech firm Tubulis for up to $5 billion, benefiting Evotec, which holds a 3.14 percent stake and expects about $100 million upfront...
Biobanks are vital for advancing rare disease research by enabling access to scarce biological samples. Experts highlighted their role in improving scientific evidence, raising awareness about...